SOX18 and neoplasm: In vivo studies using animal models or patient‐derived samples would provide a more comprehensive understanding of the therapeutic potential of SOX18 inhibition in lymphangiosarcoma treatment and its effects on tumor growth, metastasis, and overall survival.